These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2288524

  • 21. [Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
    Vergara G, Disertori M, Inama G, Guarnerio M, Bettini R, Durante G, Stirpe E, Furlanello F.
    G Ital Cardiol; 1984 Dec; 14(12):972-81. PubMed ID: 6532893
    [Abstract] [Full Text] [Related]

  • 22. [Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy].
    Bernasconi M, Pogna M, Potenza S, Marzegalli M, Cirino D.
    Cardiologia; 1989 Apr; 34(4):357-63. PubMed ID: 2758441
    [Abstract] [Full Text] [Related]

  • 23. Practical follow-up guidelines for patients treated with amiodarone.
    Podrid PJ.
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I10-6. PubMed ID: 3078154
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
    Chiale PA, Halpern MS, Nau GJ, Tambussi AM, Przybylski J, Lázzari JO, Elizari MV, Rosenbaum MB.
    Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
    [Abstract] [Full Text] [Related]

  • 25. The efficacy of amiodarone in the treatment of refractory nonsustained ventricular tachycardia.
    Ballas SL, Veltri EP.
    Md Med J; 1991 Jun; 40(6):475-8. PubMed ID: 1861575
    [Abstract] [Full Text] [Related]

  • 26. Five-year follow-up of 589 patients treated with amiodarone.
    Weinberg BA, Miles WM, Klein LS, Bolander JE, Dusman RE, Stanton MS, Heger JJ, Langefeld C, Zipes DP.
    Am Heart J; 1993 Jan; 125(1):109-20. PubMed ID: 8417505
    [Abstract] [Full Text] [Related]

  • 27. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM, Sauve MJ, Malone P, Griffin JC, Helmy I, Langberg JJ, Goldberg H, Scheinman MM.
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [Abstract] [Full Text] [Related]

  • 28. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.
    Fananapazir L, Leon MB, Bonow RO, Tracy CM, Cannon RO, Epstein SE.
    Am J Cardiol; 1991 Jan 15; 67(2):169-74. PubMed ID: 1987718
    [Abstract] [Full Text] [Related]

  • 29. Ten years of experience with amiodarone.
    Rosenbaum MB, Chiale PA, Haedo A, Lázzari JO, Elizari MV.
    Am Heart J; 1983 Oct 15; 106(4 Pt 2):957-64. PubMed ID: 6613843
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K.
    Ann N Y Acad Sci; 1992 Jan 27; 644():235-45. PubMed ID: 1562118
    [Abstract] [Full Text] [Related]

  • 31. Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia.
    Manz M, Jung W, Lüderitz B.
    Clin Investig; 1992 May 27; 70(5):416-20. PubMed ID: 1600352
    [Abstract] [Full Text] [Related]

  • 32. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
    Rasmussen K, Winkle R, Ross D, Griffin J, Peters F, Mason J.
    Acta Med Scand; 1982 May 27; 212(6):367-74. PubMed ID: 6760675
    [Abstract] [Full Text] [Related]

  • 33. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics.
    Mendoza I, Camardo J, Moleiro F, Castellanos A, Medina V, Gomez J, Acquatella H, Casal H, Tortoledo F, Puigbo J.
    Am J Cardiol; 1986 Feb 15; 57(6):423-7. PubMed ID: 3946258
    [Abstract] [Full Text] [Related]

  • 34. Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
    Kaski JC, Girotti LA, Messuti H, Rutitzky B, Rosenbaum MB.
    Circulation; 1981 Aug 15; 64(2):273-9. PubMed ID: 6788399
    [Abstract] [Full Text] [Related]

  • 35. Long-term follow-up after sustained monomorphic ventricular tachycardia: Causes, pump failure, and empiric antiarrhythmic therapy that modify survival.
    Leclercq JF, Coumel P, Denjoy I, Maisonblanche P, Cauchemez B, Chouty F, Leenhardt A, Slama R.
    Am Heart J; 1991 Jun 15; 121(6 Pt 1):1685-92. PubMed ID: 1674634
    [Abstract] [Full Text] [Related]

  • 36. [Amiodarone induced pulmonary toxicity].
    Alter P, Grimm W, Maisch B.
    Pneumologie; 2002 Jan 15; 56(1):31-5. PubMed ID: 11797156
    [Abstract] [Full Text] [Related]

  • 37. The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic Chagasic heart disease.
    Leite LR, Fenelon G, Paes AT, de Paola AA.
    Arq Bras Cardiol; 2001 Nov 15; 77(5):439-52. PubMed ID: 11733817
    [Abstract] [Full Text] [Related]

  • 38. [Radioisotopic mapping of the arrhythmogenic focus in patients with chronic chagasic cardiomyopathy and sustained ventricular tachycardia].
    de Paola AA, Balbão CE, Castiglioni ML, Barbieri A, Mendonça A, Netto OS, Guiguer Júnior N, Vattimo AC, Souza IA, Portugal OP.
    Arq Bras Cardiol; 1993 Jun 15; 60(6):373-6. PubMed ID: 8279975
    [Abstract] [Full Text] [Related]

  • 39. Right and left ventricular function during chronic amiodarone therapy.
    Sheldon RS, Mitchell LB, Duff HJ, Wyse DG, Manyari DE.
    Am J Cardiol; 1988 Oct 01; 62(10 Pt 1):736-40. PubMed ID: 3421174
    [Abstract] [Full Text] [Related]

  • 40. Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcome.
    Bauman JL, Berk SI, Hariman RJ, Langenberg PW, Deal BJ, Beckman K, Brownstein S, Gallastegui J.
    Am Heart J; 1987 Dec 01; 114(6):1436-44. PubMed ID: 3687699
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.